BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3716711)

  • 1. [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
    Guliamov MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):582-7. PubMed ID: 3716711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical therapy of depressive syndromes with Noxiptilin].
    Hohnbaum M; Sattes H
    Arzneimittelforschung; 1970 Jul; 20(7):940-3. PubMed ID: 5536065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 4. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 5. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with noxiptilin].
    König L; Lange E; Rossner M; Liefke T; Uhlig B; Kursawe HK; Lungwitz J
    Psychiatr Neurol Med Psychol (Leipz); 1976 Apr; 28(4):236-42. PubMed ID: 947276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam].
    Borromei A; Caramelli R; Conti M; Giancola LC; Guerra L
    Minerva Med; 1989 May; 80(5):475-82. PubMed ID: 2747975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
    Ivanov V; Popov G
    Agressologie; 1981 Nov; 22(D):29-30. PubMed ID: 7332038
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience in using fenazepam to treat psychotic patients].
    Nuller IuL; Tochilov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):914-20. PubMed ID: 6106340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of depressive conditions with S-methylmethionine (vitamin U)].
    Stoliarov GV; Mys'ko
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1209-12. PubMed ID: 7315057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
    Brion S; Chevalier JF; Guerin R; Ginestet D
    Encephale; 1976; 2(3):257-71. PubMed ID: 991806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of an antidepressive agent in psychiatry: Mutabon F].
    Bourgeois M
    Ann Med Psychol (Paris); 1967 Jul; 125(2):318-26. PubMed ID: 6076196
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychostimulant treatment of depressive disorders secondary to medical illness.
    Woods SW; Tesar GE; Murray GB; Cassem NH
    J Clin Psychiatry; 1986 Jan; 47(1):12-5. PubMed ID: 3941052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of luteoliberin].
    Soulairac A; Lambinet H; Neuman JC; Schally AV
    Ann Med Psychol (Paris); 1983; 141(8):876-82. PubMed ID: 6364918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limits of efficacy and tolerance of antidepressive medications].
    Ginestet D
    Encephale; 1975; 1(3):203-10. PubMed ID: 1227815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Mashkovskii MD; Polezhaeva AI; Avrutskii GIa; Vertozgadova OP; Smulevich AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1234-8. PubMed ID: 5392529
    [No Abstract]   [Full Text] [Related]  

  • 19. Viloxazine in the treatment of depressive states.
    Rydzyński Z; Gruszczyński W
    Act Nerv Super (Praha); 1979 Oct; 21(3):146-7. PubMed ID: 556241
    [No Abstract]   [Full Text] [Related]  

  • 20. [First results of symptom statistical studies on the characterization of the clinical effect profile of the antidepressive agent noxiptilin].
    Bente D; Engelmeier MP; Heinrich K; Hippius H; Schmitt W
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:889+. PubMed ID: 5819770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.